---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-047322"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2024-04-15T23:59:59+00:00"
generated_at: "2026-06-03T22:56:14.848165+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics closes $5M private placement to Syntone Ventures

## Summary
- Issued 714,286 shares and warrants to purchase 1,071,429 shares at $7.00 per share+ warrant.
- Warrant exercise price is $7.70 per share, expiring April 15, 2029.
- Sale relied on Section 4(a)(2) and Rule 506 exemptions without registration.
- Syntone Ventures LLC is the sole investor in the private placement.

## SEC filing metadata
- accession: 0001104659-24-047322
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2024-04-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/0001104659-24-047322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465924047322/tm2411870d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-047322
- JSON: https://secwatch.observer/filing/0001104659-24-047322.json
- Plain text: https://secwatch.observer/filing/0001104659-24-047322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.